Your browser doesn't support javascript.
loading
Higher susceptibility of taurine-deficient rats to seizures induced by 4-aminopyridine.
Pasantes-Morales, H; Arzate, M E; Quesada, O; Huxtable, R J.
Afiliação
  • Pasantes-Morales H; Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, D.F.
Neuropharmacology ; 26(12): 1721-5, 1987 Dec.
Article em En | MEDLINE | ID: mdl-2830554
ABSTRACT
The susceptibility of rats made deficient of taurine by treatment with guanidinoethane sulfonate (GES), to seizures induced by 4-aminopyridine was examined. Guanidinoethane sulfonate, at a concentration of 1% was administered to pregnant rats, in the drinking water 2-3 days prior to delivery and the treatment was continued during nursing. Pups were weaned to the same treatment until 6 weeks of age. This treatment decreased levels of taurine in the cerebral cortex by 70%. 4-Aminopyridine was injected intraperitoneally at doses ranging from 4-7 mg/kg. Taurine-deficient rats showed a greater susceptibility to seizures, as demonstrated by a lowered latency for clonic seizures, an increased incidence of tonic seizures and a higher postseizure mortality. These results suggest an involvement of endogenous taurine in nervous excitability.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Convulsões / Taurina / Aminopiridinas Limite: Animals Idioma: En Ano de publicação: 1987 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Convulsões / Taurina / Aminopiridinas Limite: Animals Idioma: En Ano de publicação: 1987 Tipo de documento: Article